Bryan R Kestenbaum
Overview
Explore the profile of Bryan R Kestenbaum including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
2191
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lidgard B, Hoofnagle A, Zelnick L, de Boer I, Fretts A, Kestenbaum B, et al.
Kidney Med
. 2025 Feb;
7(3):100954.
PMID: 39967827
No abstract available.
2.
Ahmadi A, Valencia A, Begue G, Norman J, Fan S, Durbin-Johnson B, et al.
Clin J Am Soc Nephrol
. 2025 Jan;
20(3):346-357.
PMID: 39847432
No abstract available.
3.
Best C, Li X, Rotter J, Prince D, Hsu S, Hoofnagle A, et al.
J Clin Endocrinol Metab
. 2025 Jan;
PMID: 39815761
Context: The response to treatment with vitamin D varies between patients. Objective: To identify genetic variants associated with the biochemical response to vitamin D3 supplementation. Design: Randomized placebo-controlled trial conducted...
4.
Ahmadi A, Valencia A, Begue G, Norman J, Fan S, Durbin-Johnson B, et al.
medRxiv
. 2024 Sep;
PMID: 39228730
Background: Mitochondria-driven oxidative/redox stress and inflammation play a major role in chronic kidney disease (CKD) pathophysiology. Compounds targeting mitochondrial metabolism may improve mitochondrial function, inflammation, and redox stress; however, there...
5.
Kiernan E, Zelnick L, Khader A, Coston T, Bailey Z, Speckmaier S, et al.
Res Sq
. 2024 Jul;
PMID: 39011119
Purpose: Previous work has identified two AKI sub-phenotypes (SP1 and SP2) characterized by differences in inflammation and endothelial dysfunction. Here we identify these sub-phenotypes using biospecimens collected in the emergency...
6.
Hsu S, Bansal N, Denburg M, Ginsberg C, Hoofnagle A, Isakova T, et al.
J Bone Miner Res
. 2024 Mar;
39(4):433-442.
PMID: 38477777
Fracture risk is high in chronic kidney disease (CKD) and underlying pathophysiology and risk factors may differ from the general population. In a cohort study of 3939 participants in the...
7.
Tucker W, Tucker B, Januszewski A, Jenkins A, Keech A, Kestenbaum B, et al.
Clin Chim Acta
. 2024 Feb;
555:117799.
PMID: 38309558
Background: Fibroblast growth factor 21 (FGF21) levels are often elevated in cardiovascular disease (CVD). However, no study has assessed its association with cardiovascular and all-cause mortality in a population free...
8.
Chotivatanapong J, Prince D, Davison S, Kestenbaum B, Oestreich T, Wong S
Kidney360
. 2024 Jan;
5(3):363-369.
PMID: 38254255
No abstract available.
9.
Limonte C, Prince D, Hoofnagle A, Galecki A, Hirsch I, Tian F, et al.
Clin J Am Soc Nephrol
. 2023 Oct;
19(1):44-55.
PMID: 37871959
Background: Whether biomarkers of tubular injury and inflammation indicate subclinical structural kidney pathology early in type 1 diabetes remains unknown. Methods: We investigated associations of biomarkers of tubular injury and...
10.
Khader A, Zelnick L, Sathe N, Kestenbaum B, Himmelfarb J, Johnson N, et al.
Am J Respir Crit Care Med
. 2023 Oct;
208(12):1335-1338.
PMID: 37870416
No abstract available.